“Everybody Loves Money:” FDA to Offer Bonuses for Faster Drug Reviews
The Food and Drug Administration (FDA) is preparing to offer cash bonuses to agency scientists who complete drug reviews ahead of schedule. The move marks another stark and consequential turn for an agency whose deep financial and institutional…